by Haemato AG | Nov 25, 2019 | Allgemein
In the third quarter of 2019 HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS consolidated revenues of EUR 47.8 million. In the considered period from January to Sep-tember 2019 the sales totaled EUR 141.8 million (previous year: EUR 212.8 million). The EBITDA...
by Haemato AG | Aug 26, 2019 | Allgemein
In the first half of 2019, HAEMATO AG achieved EBITDA of EUR 1.69 million. Sales amounted to EUR 94.0 million. In the first six months of the financial year 2019, HAEMATO AG, Berlin (ISIN: DE0006190705), achieved an IFRS consolidated revenue of EUR 94.0 million...
by Haemato AG | May 20, 2019 | Investor News
HAEMATO AG published the Annual Report 2018 on 6 May 2019. In the first quarter of 2019, HAEMATO AG’s sales amounted to EUR 48.4 million. HAEMATO AG, Berlin (ISIN: DE0006190705), published the Annual Report 2018 on 6 May 2019, as announced in advance in the...
by Haemato AG | May 7, 2019 | Investor News
In consideration of the IFRS 15 “Revenues”, which is mandatory from the financial year 2018, HAEMATO AG generated IFRS Group sales of EUR 274.1 million, an operating result (EBIT) of EUR 8.5 million and a net income of EUR 6.3 million. In the second half...
by Haemato AG | Mar 20, 2019 | Investor News
HAEMATO AG was able to achieve an EBITDA of EUR 10.0m for the fiscal year 2018 according to preliminary IFRS financial statements. HAEMATO AG, Berlin (ISIN: DE0006190705), achieved consolidated sales of EUR 274.1m (previous year: EUR 289.4m), an operating result...
